Evaluation of the Efficacy of an Intra-articular Injection of Autologous Microfat Combined With Autologous Platelet-enriched Plasma in the Treatment of Radiocarpal Osteoarthritis: a Randomized Controlled Non-inferiority Trial Versus Total Wrist Denervation (Established Standard Treatment). AMIPREP 2

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-516239-28-00

Enrollment

Registered

2024-09-06

Start date

2023-02-17

Completion date

Unknown

Last updated

2025-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Radiocarpal Osteoarthritis

Brief summary

Pain intensity measured on the visual analog scale (EVA) at 6 month after treatment

Interventions

DRUGMICROFAT 2 mL AND PLATELET RICH PLASMA HUMAN 2 mL MIXTURE

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Pain intensity measured on the visual analog scale (EVA) at 6 month after treatment	—

Countries

France

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026